Emilia Salzmann‐Manrique

Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 Trial

Peter Bader, Hermann Kreyenberg, Arend von Stackelberg et al. · Journal of Clinical Oncology · 2015 · 131 citations

Medicine, Hematology, Oncology +16

Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey

Zyrafete Kuçi, Halvard Bönig, Hermann Kreyenberg et al. · Haematologica · 2016 · 121 citations · Full text

Life Sciences, Cell Biology, Genetics +16

Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)

Peter Bader, Zyrafete Kuçi, Shahrzad Bakhtiar et al. · Bone Marrow Transplantation · 2018 · 109 citations · Full text

Pharmacy, Immunology, Cell Therapy +14

More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling

Peter Bader, Emilia Salzmann‐Manrique, Adriana Balduzzi et al. · Blood Advances · 2019 · 104 citations · Full text

Medicine, Child Health, Pediatrics +6

CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma

Tobias Bexte, Jamal Alzubi, Lisa Marie Reindl et al. · OncoImmunology · 2022 · 77 citations · Full text

Life Sciences, Immunology, Oncology +17